Insider Transactions Reported by 23 Insiders of RECURSION PHARMACEUTICALS, INC.

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT

Insiders trading volume in the past year

RECURSION PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $137,710,376 07 Dec 2021
Mubadala Investment Co PJSC 10%+ Owner $137,333,970 02 Mar 2023
Zachary Bogue Director, 10%+ Owner $39,514,048 03 Jul 2023
Blake Borgeson Director $21,659,125 -$3,432,800 -14% 03 Mar 2026
MIC Capital Partners (Public) Parallel Cayman, LP 10%+ Owner $14,688,335 01 Nov 2021
Dean Y. Li Director $13,173,956 02 Jan 2026
Michael Secora Chief Financial Officer $9,186,510 15 Nov 2024
Najat Khan CEO and President, Director $7,566,900 -$845,425 -10% 09 Mar 2026
David Hallett Chief Scientific Officer $3,829,056 17 Feb 2026
Ben R. Taylor Chief Financial Officer $3,681,674 -$130,733 -3.4% 16 Mar 2026
Christopher Gibson Director $3,245,470 -$8,097,951 -71% 09 Mar 2026
Tina Marriott President and COO $3,129,811 15 Nov 2024
Shafique Virani Chief Business Officer $1,446,192 16 Jan 2024
David J. Mauro Chief Medical Officer $1,392,024 15 Nov 2024
Ramona Doyle Chief Medical Officer $1,280,811 16 May 2022
Zavain Dar Director $582,139 02 Jan 2026
Franziska Michor Director $565,385 18 Jun 2025
CHAVEZ R. MARTIN Director $529,780 01 Apr 2024
Terry-Ann Burrell Director $514,098 01 Jul 2024
Robert Hershberg Director $328,107 18 Jun 2025
Namandje Bumpus Director $211,628 18 Jun 2025
Elaine D. Sun Director $211,628 18 Jun 2025
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC Other* 01 Nov 2021

Recent Insider Transactions by Companies or Individuals for RECURSION PHARMACEUTICALS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Ben R. Taylor RXRX Class A Common Stock Sale -0.67% $26,971 $3.39 -7,956 1,180,318 17 Mar 2026 Direct
Ben R. Taylor RXRX Class A Common Stock Tax liability -0.59% -7,075 1,188,274 16 Mar 2026 Direct
Christopher Gibson RXRX Class A Common Stock Gift -2.16% -20,000 906,556 09 Mar 2026 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 2.21% 20,000 926,556 09 Mar 2026 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -0.44% -20,000 4,523,334 09 Mar 2026 Direct
Najat Khan RXRX Class A Common Stock Sale -1.24% $94,660 $3.35 -28,298 2,262,085 09 Mar 2026 Direct
Blake Borgeson RXRX Class A Common Stock Sale -2.64% $588,200 $3.46 -170,000 6,259,863 03 Mar 2026 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.23% $138,400 $3.46 -40,000 906,556 19 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 4.41% 40,000 946,556 19 Feb 2026 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -0.87% -40,000 4,543,334 19 Feb 2026 Direct
Ben R. Taylor RXRX Class A Common Stock Sale -1.11% $41,352 $3.08 -13,426 1,195,349 18 Feb 2026 Direct
David Hallett RXRX Class A Common Stock Tax liability -1.07% -11,908 1,097,151 17 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Tax liability -2.92% -27,265 906,556 17 Feb 2026 Direct
Ben R. Taylor RXRX Class A Common Stock Tax liability -0.98% -11,908 1,208,775 17 Feb 2026 Direct
Najat Khan RXRX Class A Common Stock Tax liability -0.62% -14,280 2,290,383 17 Feb 2026 Direct
Najat Khan RXRX Class A Common Stock Tax liability -0.45% -10,364 2,304,663 06 Feb 2026 Direct
Najat Khan RXRX Class A Common Stock Award 278.8% 1,703,892 2,315,027 06 Feb 2026 Direct
Ben R. Taylor RXRX Class A Common Stock Tax liability -0.93% -11,400 1,220,683 06 Feb 2026 Direct
Ben R. Taylor RXRX Class A Common Stock Award 61.8% 470,533 1,232,083 06 Feb 2026 Direct
David Hallett RXRX Class A Common Stock Tax liability -1.02% -11,400 1,109,059 06 Feb 2026 Direct
David Hallett RXRX Class A Common Stock Award 88.6% 526,318 1,120,459 06 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Tax liability -1.1% -10,364 933,821 06 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Award 3.32% 30,346 944,185 06 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.19% $164,800 $4.12 -40,000 913,839 04 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 4.38% 40,000 953,839 04 Feb 2026 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -0.87% -40,000 4,583,334 04 Feb 2026 Direct
Blake Borgeson RXRX Class A Common Stock Sale -3.31% $924,000 $4.20 -220,000 6,429,863 03 Feb 2026 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.19% $178,800 $4.47 -40,000 913,839 20 Jan 2026 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 4.38% 40,000 953,839 20 Jan 2026 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -0.86% -40,000 4,623,334 20 Jan 2026 Direct
Blake Borgeson RXRX Class A Common Stock Sale -3.2% $959,200 $4.36 -220,000 6,649,863 06 Jan 2026 Direct
Christopher Gibson RXRX Class A Common Stock Gift -2.14% -20,000 913,839 05 Jan 2026 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.11% $170,000 $4.25 -40,000 933,839 05 Jan 2026 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 6.57% 60,000 973,839 05 Jan 2026 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -1.27% -60,000 4,663,334 05 Jan 2026 Direct
Zavain Dar RXRX Class A Common Stock Award 2.57% 3,571 142,329 02 Jan 2026 Direct
Dean Y. Li RXRX Class A Common Stock Award 0.19% 2,381 1,240,909 02 Jan 2026 Direct
Ben R. Taylor RXRX Class A Common Stock Sale -2.73% $89,381 $4.18 -21,383 761,550 29 Dec 2025 Direct
Najat Khan RXRX Class A Common Stock Sale -16.9% $548,592 $4.41 -124,403 611,135 22 Dec 2025 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.19% $180,000 $4.50 -40,000 913,839 19 Dec 2025 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 4.38% 40,000 953,839 19 Dec 2025 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -0.84% -40,000 4,723,334 19 Dec 2025 Direct
Ben R. Taylor RXRX Class A Common Stock Tax liability -0.89% -7,057 782,933 15 Dec 2025 Direct
Christopher Gibson RXRX Class A Common Stock Gift -2.14% -20,000 913,839 04 Dec 2025 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.11% $185,200 $4.63 -40,000 933,839 04 Dec 2025 Direct
Christopher Gibson RXRX Class A Common Stock Conversion of derivative security 6.57% 60,000 973,839 04 Dec 2025 Direct
Christopher Gibson RXRX Class B Common Stock Conversion of derivative security -1.24% -60,000 4,763,334 04 Dec 2025 Direct
Blake Borgeson RXRX Class A Common Stock Sale -3.1% $961,400 $4.37 -220,000 6,869,863 02 Dec 2025 Direct
Ben R. Taylor RXRX Class A Common Stock Tax liability -0.29% -2,271 789,990 25 Nov 2025 Direct
Christopher Gibson RXRX Class A Common Stock Sale -4.19% $166,400 $4.16 -40,000 913,839 19 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.